Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Agricultural Inputs

Arcadia Biosciences, Inc., a consumer-driven agricultural technology company, engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company`s crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; nutritional oils; and HB4, a drought and herbicide tolerant soybean trait. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Canada, Africa, and India. The company was founded in 2002 and is headquartered in Davis, California.
Website: arcadiabio.com


  • Bad financial results growth rate 0.0% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-8.7%)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield -103.4% (LTM)
  • Share price is 76.7% higher than minimum and 80.2% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (0.8x vs 1.0x)
  • Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: RKDA
Share price, USD:  (-5.6%)3.34
year average price 4.17  


year start price 2.76 2024-10-14

min close price 2.59 2024-11-21

max close price 6.40 2024-12-10

current price 3.33 2025-10-13
Common stocks: 1 366 060

Dividend Yield:  0.0%
FCF Yield LTM: -103.4%
EV / LTM EBITDA: 0.8x
EV / Sales: 0.2x
Margin (EBITDA LTM / Revenue): 20.0%

Target EV / EBITDA (hist percentile): 1.0x
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 5
Net Debt ($m): -4
EV (Enterprise Value): 1
EBITDA LTM (млн $): 1
EV / LTM EBITDA: 0.8x
Price to Book: 0.5x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-05-11seekingalpha.com

Arcadia Biosciences, Inc. (RKDA) Q1 2025 Earnings Call Transcript

2025-03-20seekingalpha.com

Arcadia Biosciences, Inc (RKDA) Q4 2024 Earnings Call Transcript

2025-03-06businesswire.com

Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2024 Financial Results and Business Highlights Conference Call

2025-02-24businesswire.com

RKDA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arcadia Biosciences, Inc. is Fair to Shareholders

2024-12-09zacks.com

Arcadia Biosciences to Merge With Roosevelt, Shares Surge 105%

2024-12-06prnewswire.com

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Arcadia Biosciences, Inc. - RKDA

2024-12-06prnewswire.com

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Arcadia Biosciences, Inc.

2024-12-06businesswire.com

Shareholder Alert: Ademi LLP investigates whether Arcadia Biosciences, Inc. is obtaining a Fair Price for its Public Shareholders

2024-12-05businesswire.com

RKDA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arcadia Biosciences, Inc. Is Fair to Shareholders

2024-12-05businesswire.com

Arcadia Biosciences (RKDA) Enters Into Business Combination Agreement with Roosevelt Resources in All-Stock Transaction
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA
reportedCurrency USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2024-11-12 2024-08-13 2024-05-13 2024-03-28 2023-11-09 2023-08-10 2023-05-15 2023-03-30 2022-11-10 2022-08-11
acceptedDate 2024-11-12 17:00:09 2024-08-13 17:16:56 2024-05-13 15:31:07 2024-03-28 17:20:44 2023-11-09 17:03:55 2023-08-10 17:09:15 2023-05-15 16:08:46 2023-03-30 17:09:24 2022-11-10 16:53:05 2022-08-11 17:09:18
calendarYear 2024 2024 2024 2023 2023 2023 2023 2022 2022 2022
period Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3 Q2
revenue 2M 1M 1M 1M 2M 1M 2M 1 000 000 2M 4M
costOfRevenue 1M 633 000 820 000 670 000 1M 981 000 825 000 2M 1M 3M
grossProfit 505 000 673 000 435 000 500 000 495 000 408 000 684 000 -552 000 534 000 411 000
grossProfitRatio 0.329 0.515 0.347 0.427 0.31 0.294 0.453 -0.552 0.284 0.107
researchAndDevelopmentExpenses 24 000 10000 272 000 332 000 305 000 391 000 359 000 500 000 255 000 359 000
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 2M 3M 3M 3M 3M 4M 4M 4M 5M 5M
otherExpenses 0 0 3000 12 000 17 000 -13 000 32 000 20 000 0 0
operatingExpenses 2M 3M 3M 4M 4M 4M 5M 5M 5M 5M
costAndExpenses 3M 3M 4M 4M 5M 5M 6M 6M 6M 8M
interestIncome 233 000 150 000 45 000 157 000 133 000 207 000 0 0 0 0
interestExpense 0 0 0 -198 000 0 0 198 000 194 000 95 000 30 000
depreciationAndAmortization 7000 34 000 228 000 222 000 89 000 67 000 -38 000 -115 000 -2M 141 000
ebitda -2M -2M -3M -3M -3M -8M -4M -6M -6M -4M
ebitdaratio -1.141 -1.521 -2.229 -2.592 -2.03 -5.87 -2.708 -5.945 -3.366 -0.94
operatingIncome -2M 2M -3M -3M -3M -4M -4M -6M -5M -4M
operatingIncomeRatio -1.145 1.516 -2.411 -2.782 -2.03 -2.729 -2.683 -5.83 -2.426 -0.981
totalOtherIncomeExpensesNet 578 000 -130 000 603 000 639 000 758 000 4M 19 000 2M 2M -14 000
incomeBeforeTax -1M 2M -2M -3M -2M 819 000 -4M -4M -3M -4M
incomeBeforeTaxRatio -0.769 1.417 -1.931 -2.236 -1.555 0.59 -2.683 -4.315 -1.531 -0.984
incomeTaxExpense 430 000 0 184 724 7000 83 000 1000 -198 000 13 000 1000 -20 000
netIncome -2M 1M -2M -3M -3M 823 000 -4M -4M -3M -4M
netIncomeRatio -1.049 0.812 -1.931 -2.438 -1.607 0.593 -2.551 -4.328 -1.532 -0.979
eps -1.18 0.78 -1.78 -2.22 -1.89 0.61 -4.49 -7.22 -4.69 -0.17
epsdiluted -1.18 0.78 -1.78 -2.22 -1.89 0.61 -4.49 -7.22 -4.69 -0.17
weightedAverageShsOut 1M 1M 1M 1M 1M 1M 857 572 599 389 613 813 22M
weightedAverageShsOutDil 1M 1M 1M 1M 1M 1M 857 572 599 389 613 813 22M
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA
reportedCurrency USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2024-11-12 2024-08-13 2024-05-13 2024-03-28 2023-11-09 2023-08-10 2023-05-15 2023-03-30 2022-11-10 2022-08-11
acceptedDate 2024-11-12 17:00:09 2024-08-13 17:16:56 2024-05-13 15:31:07 2024-03-28 17:20:44 2023-11-09 17:03:55 2023-08-10 17:09:15 2023-05-15 16:08:46 2023-03-30 17:09:24 2022-11-10 16:53:05 2022-08-11 17:09:18
calendarYear 2024 2024 2024 2023 2023 2023 2023 2022 2022 2022
period Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3 Q2
cashAndCashEquivalents 4M 6M 3M 7M 11M 13M 23M 21M 23M 21M
shortTermInvestments 3M 3M 5M 5M 5M 5M 0 0 0 0
cashAndShortTermInvestments 7M 8M 9M 12M 16M 19M 23M 21M 23M 21M
netReceivables 3M 3M 760 000 514 000 304 000 630 000 923 000 1M 3M 4M
inventory 835 000 978 000 2M 2M 3M 3M 3M 3M 3M 3M
otherCurrentAssets 591 000 749 000 550 000 858 000 1M 951 000 606 000 809 000 990 000 2M
totalCurrentAssets 11M 12M 12M 15M 20M 23M 27M 25M 30M 30M
propertyPlantEquipmentNet 361 000 567 000 1M 1M 2M 2M 2M 3M 3M 3M
goodwill 0 0 0 0 0 0 0 0 0 0
intangibleAssets 39 000 39 000 39 000 39 000 40 000 40 000 40 000 40 000 373 000 386 000
goodwillAndIntangibleAssets 39 000 39 000 39 000 39 000 40 000 40 000 40 000 40 000 373 000 386 000
longTermInvestments 0 0 0 0 0 0 0 0 0 0
taxAssets 0 0 0 0 0 0 0 0 0 0
otherNonCurrentAssets 4M 4M 3M 4M 2M 1M 925 000 932 000 1M 1M
totalNonCurrentAssets 5M 5M 4M 5M 3M 3M 3M 4M 4M 5M
otherAssets 0 0 0 1 0 0 0 0 0 0
totalAssets 15M 17M 16M 20M 23M 27M 30M 29M 34M 35M
accountPayables 2M 2M 2M 2M 3M 3M 3M 931 000 3M 3M
shortTermDebt 0 1M 801 000 852 000 924 000 993 000 1M 1M 986 000 994 000
taxPayables 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 46 000 33 000 0 0 0 0
otherCurrentLiabilities 636 000 12 000 345 000 328 000 313 000 282 000 298 000 2M 317 000 355 000
totalCurrentLiabilities 2M 3M 3M 4M 4M 4M 4M 4M 4M 5M
longTermDebt 0 11 000 21 000 155 000 347 000 532 000 760 000 1M 1M 2M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 3M 3M 3M 3M 4M 4M 9M 3M 2M 2M
totalNonCurrentLiabilities 3M 3M 3M 3M 4M 5M 10M 4M 5M 4M
otherLiabilities 0 0 1 0 0 0 0 0 0 0
capitalLeaseObligations 0 574 000 21 000 155 000 1M 2M 2M 2M 2M 2M
totalLiabilities 5M 6M 6M 7M 8M 9M 14M 8M 9M 8M
preferredStock 0 0 0 0 2M 0 0 0 0 0
commonStock 65 000 65 000 65 000 65 000 65 000 65 000 65 000 65 000 65 000 63 000
retainedEarnings -275M -273M -274M -272M -269M -266M -267M -258M -254M -251M
accumulatedOtherComprehensiveIncomeLoss 117 000 81 000 161 000 101 000 87 000 21 000 0 0 0 0
othertotalStockholdersEquity 285M 285M 285M 285M 283M 284M 284M 279M 279M 277M
totalStockholdersEquity 10M 12M 11M 13M 16M 18M 17M 21M 25M 27M
totalEquity 10M 12M 10M 13M 15M 18M 17M 21M 25M 27M
totalLiabilitiesAndStockholdersEquity 15M 17M 16M 20M 23M 27M 30M 29M 34M 35M
minorityInterest -138 000 -138 000 -138 000 -138 000 -138 000 -138 000 -133 000 -133 000 0 0
totalLiabilitiesAndTotalEquity 15M 17M 16M 20M 23M 27M 30M 29M 34M 35M
totalInvestments 3M 3M 5M 5M 5M 5M 0 0 0 0
totalDebt 346 000 574 000 822 000 1M 1M 2M 2M 2M 2M 2M
netDebt -4M -5M -2M -6M -9M -12M -21M -19M -20M -19M
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link

Cash Flow Statement

Property 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA
reportedCurrency USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2024-11-12 2024-08-13 2024-05-13 2024-04-29 2023-11-09 2023-08-10 2023-05-15 2023-03-30 2022-11-10 2022-08-11
acceptedDate 2024-11-12 17:00:09 2024-08-13 17:16:56 2024-05-13 15:31:07 2024-04-29 14:07:07 2023-11-09 17:03:55 2023-08-10 17:09:15 2023-05-15 16:08:46 2023-03-30 17:09:24 2022-11-10 16:53:05 2022-08-11 17:09:18
calendarYear 2024 2024 2024 2023 2023 2023 2023 2022 2022 2022
period Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3 Q2
netIncome -2M 1M -2M -3M -3M 818 000 -9M -4M -3M -4M
depreciationAndAmortization -153 000 17 000 228 000 222 000 89 000 67 000 71 000 86 000 90 000 141 000
deferredIncomeTax 0 0 0 -2M -796 000 -10M 0 0 0 0
stockBasedCompensation 155 000 102 000 138 000 144 000 162 000 199 000 212 000 209 000 314 000 323 000
changeInWorkingCapital 736 000 -138 000 -598 000 -1M -381 000 -2M -115 000 2M 1M -2M
accountsReceivables -111 000 -88 000 -246 000 -65 000 162 000 7000 80 000 1M 2M -1M
inventory -286 000 137 000 303 000 -1M -72 000 -1M -37 000 47 000 70 000 332 000
accountsPayables -107 000 66 000 -678 000 -222 000 -151 000 0 -149 000 133 000 -643 000 -49 000
otherWorkingCapital 1M -253 000 23 000 109 999 -320 000 -532 000 -9000 901 000 -304 000 0
otherNonCashItems -89 000 -3M 660 000 1M 608 000 6M 6M -530 000 -2M 1M
netCashProvidedByOperatingActivities -2M -2M -3M -4M -3M -5M -3M -2M -3M -3M
investmentsInPropertyPlantAndEquipment 2M -2M -13 000 -52 000 0 -5000 0 -26 000 0 -6000
acquisitionsNet 0 -2M 17 000 73 000 5000 284 000 285 000 284 000 285 000 0
purchasesOfInvestments 0 0 0 -3M 0 -5M 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 3M 0 5M 0 0 0 0
otherInvestingActivites -2M 9M 17 000 52 000 5000 -5M 30 000 23 000 56 000 54 000
netCashUsedForInvestingActivites 180 000 5M 4000 52 000 5000 -5M 315 000 281 000 341 000 48 000
debtRepayment 0 0 0 -764 000 -382 000 -191 000 0 -932 000 0 -446 000
commonStockIssued -5000 0 5000 -7000 7000 0 6M 0 5M 0
commonStockRepurchased 0 0 0 -85M 0 85M 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0 0
otherFinancingActivites 4000 0 5000 771 000 382 000 191 000 -492 000 936 000 -485 000 446 000
netCashUsedProvidedByFinancingActivities 4000 0 5000 -85M 7000 85M 6M 4000 5M 0
effectOfForexChangesOnCash 0 0 0 85M 0 -85M 0 -4000 0 0
netChangeInCash -2M 2M -3M -4M -3M -10M 2M -2M 1M -3M
cashAtEndOfPeriod 4M 6M 3M 7M 11M 13M 23M 21M 23M 21M
cashAtBeginningOfPeriod 6M 3M 7M 11M 13M 23M 21M 23M 21M 25M
operatingCashFlow -2M -2M -3M -4M -3M -5M -3M -2M -3M -3M
capitalExpenditure 2M -3000 -13 000 -52 000 0 -5000 0 -26 000 0 -6000
freeCashFlow 248 000 -2M -3M -4M -3M -5M -3M -2M -3M -3M
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link

Earning call transcript

2024 q3
2024-11-12 ET (fiscal 2024 q3)
2024 q2
2024-08-13 ET (fiscal 2024 q2)
2024 q1
2024-05-09 ET (fiscal 2024 q1)
2023 q4
2024-03-28 ET (fiscal 2023 q4)
2023 q3
2023-11-10 ET (fiscal 2023 q3)
2023 q2
2023-08-10 ET (fiscal 2023 q2)
2023 q1
2023-05-11 ET (fiscal 2023 q1)
2022 q4
2023-03-30 ET (fiscal 2022 q4)
2022 q3
2022-11-10 ET (fiscal 2022 q3)
2022 q2
2022-08-11 ET (fiscal 2022 q2)
2022 q1
2022-05-12 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-03-28 20:05 ET
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2023 Financial Results and Business Highlights
2024-03-14 12:02 ET
Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2023 Financial Results and Business Highlights Conference Call
2024-02-20 13:02 ET
Arcadia Biosciences (RKDA) Expands GoodWheat™ Mac & Cheese with Nationwide Availability
2023-11-09 21:05 ET
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2023 Financial Results and Business Highlights
2023-10-26 12:02 ET
Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2023 Financial Results and Business Highlights Conference Call
2023-10-03 12:02 ET
GoodWheat™ Introduces Clean Plate Guarantee, Celebrates Picky Eaters for National Pasta Month
2023-09-05 12:02 ET
Arcadia Biosciences (RKDA) to Participate in Upcoming Investor Conferences
2023-08-10 20:05 ET
Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2023 Financial Results and Business Highlights
2023-07-27 14:19 ET
Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2023 Financial Results and Business Highlights Conference Call
2023-07-20 12:02 ET
Arcadia Biosciences (RKDA) Announces Strategic Review
2023-07-17 12:02 ET
Arcadia Biosciences (RKDA) Launches GoodWheat™ into the Breakfast Category with New Better-For-You Pancake & Waffle Mixes and Single-Serve Quikcakes™
2023-05-11 20:05 ET
Arcadia Biosciences (RKDA) Announces First Quarter 2023 Financial Results from Operations and Business Highlights
2023-05-08 12:01 ET
GoodWheat™ Pasta Named “Best New Product” By Retail Dietitians Business Alliance
2023-04-28 12:02 ET
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2023 Financial Results and Business Highlights Conference Call
2023-03-30 20:05 ET
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2022 Financial Results and Business Highlights
2023-03-22 12:02 ET
Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2022 Financial Results and Business Highlights Conference Call
2023-03-03 00:00 ET
Arcadia Biosciences (RKDA) Announces $6.0 Million Private Placement Priced at a Premium to Market Under Nasdaq Rules
2023-01-18 13:00 ET
GoodWheat™ Pasta Receives American Heart Association® Heart-Check Certification
2022-12-08 13:00 ET
Arcadia Biosciences (RKDA) Doubles Retail Footprint for GoodWheat™ Pasta
2022-11-30 21:30 ET
Arcadia Biosciences (RKDA) Announces CFO Transition
2022-11-10 21:05 ET
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2022 Financial Results and Business Highlights
2022-10-27 12:00 ET
Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2022 Financial Results and Business Highlights Conference Call
2022-08-31 12:00 ET
Arcadia Biosciences (RKDA) to Participate in Upcoming Investor Conferences
2022-08-12 23:10 ET
Arcadia Biosciences (RKDA) Announces $5.0 Million Registered Direct Offering Priced At-The-Market
2022-08-11 20:05 ET
Arcadia Biosciences (RKDA) Announces Strong Second-Quarter and First-Half 2022 Financial Results and Business Highlights
2022-07-28 12:00 ET
Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2022 Financial Results and Business Highlights Conference Call
2022-06-01 13:00 ET
NEW GOODWHEAT™ PASTA SERVES UP PASTA REVOLUTION WITH FORKFUL OF FIBER THAT NEVER TASTED SO GOOD
2022-05-12 20:05 ET
Arcadia Biosciences (RKDA) Announces First Quarter 2022 Financial Results
2022-05-05 12:00 ET
Arcadia Biosciences Announces Date of First Quarter 2022 Financial Results and Business Highlights Conference Call
2022-03-30 20:05 ET
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2021 Financial Results and Business Highlights
2022-03-23 12:00 ET
Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2021 Financial Results and Business Highlights Conference Call
2022-02-02 21:05 ET
Arcadia Biosciences (RKDA) Names Stan Jacot as CEO
2021-12-20 15:55 ET
Arcadia Biosciences (RKDA) Appoints Kevin Comcowich to Interim CEO
2021-11-22 13:00 ET
Arcadia Biosciences (RKDA) Appoints Seasoned CPG Sales Executive Brian Schaffer to Senior Vice President of Sales
2021-11-15 21:05 ET
Arcadia Biosciences (RKDA) Announces Strong Third-Quarter Financial Results and Business Highlights
2021-11-08 13:00 ET
Arcadia Biosciences (RKDA) Announces Date of Third-Quarter 2021 Financial Results and Business Highlights Conference Call
2021-09-07 20:10 ET
Arcadia Biosciences Announces Leadership Transition
2021-08-16 20:05 ET
Arcadia Biosciences Announces Strong Second-Quarter and First-Half 2021 Financial Results and Business Highlights
2021-08-09 12:00 ET
Arcadia Biosciences (RKDA) Announces Date of Second-Quarter and First-Half 2021 Financial Results and Business Highlights Conference Call
2021-07-20 11:00 ET
Arcadia Biosciences (RKDA) Names Veteran CPG Leader Laura Pitlik Chief Marketing Officer
2021-05-17 20:05 ET
Arcadia Biosciences (RKDA) Announces First-Quarter 2021 Financial Results and Business Highlights
2021-05-17 20:02 ET
Arcadia Biosciences (RKDA) Acquires Lief Brands, a Portfolio of CBD and Wellness Brands
2021-05-10 12:30 ET
Arcadia Biosciences Announces Date of First Quarter 2021 Financial Results and Business Highlights Conference Call
2021-05-10 12:00 ET
Belinda Yao joins Arcadia Biosciences (RKDA) as Vice President of Operations
2021-04-20 12:00 ET
Arcadia Biosciences (RKDA) Receives Health Canada Approval for GoodHemp™ Varieties
2021-04-19 12:00 ET
Arcadia Biosciences (RKDA) Acquires European Food Ingredient Platform that Further Enhances its GoodWheat™ Business
2021-03-30 20:05 ET
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2020 Financial Results and Business Highlights
2021-03-23 12:00 ET
Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2020 Financial Results and Business Highlights Conference Call
2021-03-04 13:00 ET
Arcadia Biosciences (RKDA) Expands GoodWheat™ Patent Portfolio
2021-03-02 13:00 ET
Arcadia Biosciences (RKDA) to Present at H.C. Wainwright's Global Life Sciences Conference March 9-10, 2021
2021-02-24 18:04 ET
Arcadia Biosciences Welcomes Debbie Carosella to Board Of Directors
2021-02-02 13:00 ET
GoodHemp™ Seed Varieties Earn AOSCA Certification
2021-01-25 14:00 ET
Arcadia Biosciences (RKDA) Announces $25.1 Million Private Placement
2020-12-18 14:02 ET
Arcadia Biosciences (RKDA) Announces $8.0 Million Registered Direct Offering Priced At-the-Market
2020-11-24 13:00 ET
Arcadia Biosciences (RKDA) Signs Hemp Distribution Agreement with Tritium 3H
2020-11-12 13:05 ET
Arcadia Biosciences (RKDA) Announces a Series of Strategic Transactions with Bioceres Crop Solutions (BIOX)
2020-11-12 13:00 ET
Arcadia Biosciences (RKDA) Announces Third-Quarter 2020 Financial Results and Business Highlights
2020-11-10 13:00 ET
Three Farm Daughters™ Launches New Product Portfolio Powered by GoodWheat™
2020-11-06 13:00 ET
Arcadia Biosciences Announces Date of Third Quarter 2020 Financial Results and Business Highlights Conference Call
2020-09-17 12:00 ET
Arcadia Biosciences (RKDA) Expands Leadership Team with New Heads of Commercial Operations and Product Innovation
2020-09-09 12:00 ET
Arcadia Biosciences (RKDA) to Present at H.C. Wainwright's 22nd Annual Global Investment Conference September 14-16, 2020
2020-09-01 12:00 ET
Arcadia Biosciences (RKDA) Completes Purchase of Industrial Seed Innovations, Acquires Proprietary Hemp Varieties
2020-08-13 20:05 ET
Arcadia Biosciences Announces Second-Quarter and First-Half 2020 Financial Results and Business Highlights
2020-08-12 12:00 ET
Arcadia Biosciences (RKDA) Collaborates with GoodMills Innovation to Sell GoodWheat™ in Europe
2020-08-10 12:00 ET
Arcadia Biosciences (RKDA) Announces Partnership with Three Farm Daughters to Develop and Market GoodWheat™-Branded Wheat Products
2020-08-06 12:00 ET
Arcadia Biosciences Announces Collaboration with Corner Foods to Commercialize GoodWheat™ Technology
2020-07-30 15:00 ET
Arcadia Biosciences Announces Date of Second Quarter and First Half 2020 Financial Results and Business Highlights Conference Call
2020-07-06 13:23 ET
Arcadia Biosciences Announces Warrant Exercise Transaction to Generate $2.5 Million in Gross Proceeds
2020-06-18 12:00 ET
Arcadia Biosciences Receives Foundational Patents for Non-GMO Herbicide Tolerant Wheat Traits
2020-06-17 12:00 ET
Arcadia Biosciences to Join Russell Microcap® Index
2020-06-10 12:00 ET
Arcadia Biosciences Announces Plans to Acquire Oregon-Based Industrial Seed Innovations
2020-05-18 15:30 ET
Arcadia Biosciences Announces Cash Proceeds of $6.8 Million from Warrant Exercise
2020-05-13 20:05 ET
Arcadia Biosciences Announces First-Quarter 2020 Financial Results and Business Highlights
2020-05-07 12:00 ET
Arcadia Biosciences Significantly Expands Intellectual Property Portfolio with Four U.S. Patents
2020-05-06 12:00 ET
Arcadia Biosciences Announces Date of First Quarter 2020 Financial Results and Business Highlights Conference Call
2020-04-01 12:00 ET
Arcadia Biosciences Promotes Randy Shultz, Ph.D. to Chief Technology Officer
2020-03-25 20:05 ET
Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights
2020-03-23 12:00 ET
Arcadia Biosciences and Archipelago Ventures Announce Strategic Partnership with Vivion Specialties, Inc. to Certify and Distribute Hawaiian Hemp Products Across North America
2020-03-19 12:00 ET
Arcadia Biosciences Partners with Grow West® and Buttonwillow Warehouse Company to Bring GoodHemp Seeds to California Growers
2020-03-11 12:00 ET
Arcadia Biosciences Announces Date of Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights Conference Call
2020-03-10 12:00 ET
Verdeca Showcases HB4® Drought Tolerant Soybeans to Growers and Enrolls Early Adopters at Expoagro in Argentina
2020-02-27 13:00 ET
Arcadia Biosciences Receives U.S. Patent for High Fiber Wheat with Improved Yield
2020-01-30 15:00 ET
Arcadia Biosciences Announces Over $3 Million in Pre-Season GoodHemp Seed Purchase Commitments
2020-01-30 13:00 ET
Arcadia Biosciences Letter to Shareholders
2019-11-12 13:00 ET
Verdeca Receives Approval of HB4® Drought and Herbicide Tolerant Soybeans in Paraguay
2019-11-05 09:00 ET
Arcadia Biosciences Announces Wheat Purchase Commitment, Significant Increase in GoodWheat(TM) Harvest Acres
2019-10-30 12:00 ET
Arcadia Biosciences Announces Date of Third-Quarter 2019 Financial Results and Business Highlights Conference Call
2019-10-15 08:00 ET
Arcadia Biosciences Advances Hemp Operations with Archipelago Ventures
2019-09-23 13:31 ET
Thinking about buying stock in Aurora Cannabis, Beyond Meat, Exact Sciences, Plus Therapeutics, or Arcadia Biosciences?
2019-09-23 08:00 ET
Arcadia Biosciences Granted U.S. Patent for Reduced Gluten GoodWheat
2019-09-10 15:37 ET
Arcadia Biosciences Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market
2019-09-05 08:00 ET
Arcadia Specialty Genomics(TM) Expands Hemp Operations with New Sun-Grown Cultivation and Research Facility in California
2019-09-04 12:00 ET
Arcadia Biosciences to Present at 21st Annual Global Investment Conference September 8-10, 2019
2019-08-26 08:15 ET
Arcadia Biosciences Announces Management Succession; Provides Financial Guidance
2019-08-26 08:00 ET
Arcadia Biosciences Enters Global Collaboration with Arista Cereal Technologies and Bay State Milling Company for Commercialization of High Fiber Wheat
2019-08-15 13:31 ET
Thinking about buying stock in Aurora Cannabis, Alibaba, Canopy Growth, Arcadia Biosciences, or Walmart?
2019-08-14 20:08 ET
Arcadia Biosciences Announces Second-Quarter and First-Half 2019 Financial Results and Business Highlights
2019-08-12 13:31 ET
Thinking about buying stock in Aurora Cannabis, Arcadia Biosciences, Roku, Tilray, or Yangtze River Port and Logistics?
2019-08-09 13:31 ET
Thinking about buying stock in Aurora Cannabis, Activision Blizzard, Arcadia Biosciences, Tilray, or Uber Technologies?
2019-08-09 00:30 ET
Verdeca Receives USDA Approval of HB4® Drought Tolerant Soybeans
2019-08-06 12:45 ET
Arcadia Biosciences Announces Joint Venture with Legacy Ventures Hawaii To Grow, Extract and Sell Superior Hemp Products
2019-08-05 20:37 ET
Arcadia Biosciences Announces Date of Second-Quarter 2019 Financial Results and Business Highlights Conference Call
2019-06-18 13:00 ET
Arcadia Biosciences Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market
2019-06-13 13:00 ET
Arcadia Biosciences Announces $7.5 Million Registered Direct Offering Priced At-the-Market

SEC forms

Show financial reports only

SEC form 10
2025-08-14 21:02 ET
Arcadia Biosciences reported for 2025 q2
SEC form 8
2025-08-14 20:33 ET
Arcadia Biosciences published news for 2025 q2
SEC form 8
2025-08-14 20:33 ET
Arcadia Biosciences published news for 2025 q2
SEC form 8
2025-08-14 20:33 ET
Arcadia Biosciences published news for 2025 q2
SEC form 8
2025-05-16 21:21 ET
Arcadia Biosciences published news for 2025 q1
SEC form 10
2025-05-08 12:07 ET
Arcadia Biosciences published news for 2025 q1
SEC form 10
2025-05-08 00:00 ET
Arcadia Biosciences reported for 2025 q1
SEC form 8
2025-05-08 00:00 ET
Arcadia Biosciences published news for 2025 q1
SEC form 8
2025-05-08 00:00 ET
Arcadia Biosciences published news for 2025 q1
SEC form 8
2025-05-08 00:00 ET
Arcadia Biosciences published news for 2025 q1
SEC form 8
2025-05-02 21:01 ET
Arcadia Biosciences published news for 2025 q1
SEC form 8
2025-05-02 21:01 ET
Arcadia Biosciences published news for 2025 q1
SEC form 8
2025-04-03 20:15 ET
Arcadia Biosciences published news for 2025 q1
SEC form 10
2025-03-25 20:44 ET
Arcadia Biosciences published news for 2024 q4
SEC form 10
2025-03-25 00:00 ET
Arcadia Biosciences published news for 2024 q4
SEC form 8
2025-03-20 00:00 ET
Arcadia Biosciences published news for 2024 q4
SEC form 8
2025-03-20 00:00 ET
Arcadia Biosciences published news for 2024 q4
SEC form 8
2025-03-20 00:00 ET
Arcadia Biosciences reported for 2024 q4
SEC form 10
2024-11-12 17:00 ET
Arcadia Biosciences reported for 2024 q3
SEC form 8
2024-11-12 16:10 ET
Arcadia Biosciences published news for 2024 q3
SEC form 8
2024-11-12 16:10 ET
Arcadia Biosciences published news for 2024 q3
SEC form 8
2024-11-12 16:10 ET
Arcadia Biosciences published news for 2024 q3
SEC form 10
2024-11-12 00:00 ET
Arcadia Biosciences published news for 2024 q3
SEC form 10
2024-08-13 00:00 ET
Arcadia Biosciences reported for 2024 q2
SEC form 8
2024-08-13 00:00 ET
Arcadia Biosciences published news for 2024 q2
SEC form 8
2024-08-13 00:00 ET
Arcadia Biosciences published news for 2024 q2
SEC form 8
2024-08-13 00:00 ET
Arcadia Biosciences published news for 2024 q2
SEC form 10
2024-05-13 00:00 ET
Arcadia Biosciences published news for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Arcadia Biosciences published news for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Arcadia Biosciences published news for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Arcadia Biosciences reported for 2024 q1
SEC form 10
2024-03-28 17:20 ET
Arcadia Biosciences published news for 2023 q4
SEC form 8
2024-03-28 17:02 ET
Arcadia Biosciences published news for 2023 q4
SEC form 8
2024-03-28 17:02 ET
Arcadia Biosciences published news for 2023 q4
SEC form 8
2024-03-28 17:02 ET
Arcadia Biosciences reported for 2023 q4
SEC form 10
2024-03-28 00:00 ET
Arcadia Biosciences published news for 2023 q4
SEC form 10
2023-11-09 17:03 ET
Arcadia Biosciences reported for 2023 q3
SEC form 8
2023-11-09 16:10 ET
Arcadia Biosciences published news for 2023 q3
SEC form 10
2023-11-09 00:00 ET
Arcadia Biosciences published news for 2023 q3
SEC form 10
2023-08-10 17:09 ET
Arcadia Biosciences published news for 2023 q2
SEC form 6
2023-08-10 16:19 ET
Arcadia Biosciences reported for 2023 q2
SEC form 10
2023-08-10 00:00 ET
Arcadia Biosciences published news for 2023 q2
SEC form 8
2023-08-10 00:00 ET
Arcadia Biosciences published news for 2023 q2
SEC form 6
2023-07-20 14:55 ET
Arcadia Biosciences published news for 2023 q2
SEC form 8
2023-07-20 00:00 ET
Arcadia Biosciences published news for 2023 q2
SEC form 6
2023-06-12 16:12 ET
Arcadia Biosciences published news for 2023 q1
SEC form 10
2023-05-15 00:00 ET
Arcadia Biosciences published news for 2023 q1
SEC form 6
2023-05-11 16:26 ET
Arcadia Biosciences published news for 2023 q1
SEC form 8
2023-05-11 00:00 ET
Arcadia Biosciences published news for 2023 q1
SEC form 6
2023-04-13 16:07 ET
Arcadia Biosciences published news for 2023 q1
SEC form 10
2023-03-30 17:09 ET
Arcadia Biosciences reported for 2022 q4
SEC form 6
2023-03-30 16:07 ET
Arcadia Biosciences published news for 2022 q4
SEC form 10
2023-03-30 00:00 ET
Arcadia Biosciences reported for 2022 q4
SEC form 8
2023-03-30 00:00 ET
Arcadia Biosciences reported for 2022 q4
SEC form 6
2023-03-03 16:16 ET
Arcadia Biosciences published news for 2022 q4
SEC form 6
2023-02-28 16:12 ET
Arcadia Biosciences published news for 2022 q4
SEC form 6
2023-02-22 16:10 ET
Arcadia Biosciences published news for 2022 q4
SEC form 6
2023-01-06 16:11 ET
Arcadia Biosciences published news for 2022 q4
SEC form 6
2023-01-05 16:14 ET
Arcadia Biosciences published news for 2022 q4
SEC form 6
2022-12-23 16:12 ET
Arcadia Biosciences published news for 2022 q3
SEC form 6
2022-12-08 16:18 ET
Arcadia Biosciences published news for 2022 q3
SEC form 6
2022-11-30 16:32 ET
Arcadia Biosciences published news for 2022 q3
SEC form 10
2022-11-10 16:53 ET
Arcadia Biosciences reported for 2022 q3
SEC form 6
2022-11-10 16:11 ET
Arcadia Biosciences published news for 2022 q3
SEC form 10
2022-11-10 00:00 ET
Arcadia Biosciences reported for 2022 q3
SEC form 8
2022-11-10 00:00 ET
Arcadia Biosciences reported for 2022 q3
SEC form 6
2022-09-27 16:46 ET
Arcadia Biosciences published news for 2022 q2
SEC form 6
2022-08-16 17:00 ET
Arcadia Biosciences published news for 2022 q2
SEC form 10
2022-08-11 17:09 ET
Arcadia Biosciences reported for 2022 q2
SEC form 6
2022-08-11 16:07 ET
Arcadia Biosciences published news for 2022 q2
SEC form 10
2022-08-11 00:00 ET
Arcadia Biosciences reported for 2022 q2
SEC form 8
2022-08-11 00:00 ET
Arcadia Biosciences reported for 2022 q2
SEC form 6
2022-06-07 16:44 ET
Arcadia Biosciences published news for 2022 q1
SEC form 10
2022-05-12 16:59 ET
Arcadia Biosciences reported for 2022 q1
SEC form 6
2022-05-12 16:07 ET
Arcadia Biosciences published news for 2022 q1
SEC form 10
2022-05-12 00:00 ET
Arcadia Biosciences reported for 2022 q1
SEC form 8
2022-05-12 00:00 ET
Arcadia Biosciences reported for 2022 q1
SEC form 6
2022-04-19 13:51 ET
Arcadia Biosciences published news for 2022 q1
SEC form 10
2022-03-31 17:30 ET
Arcadia Biosciences published news for 2021 q4
SEC form 10
2022-03-31 00:00 ET
Arcadia Biosciences published news for 2021 q4
SEC form 6
2022-03-30 16:09 ET
Arcadia Biosciences published news for 2021 q4
SEC form 8
2022-03-30 00:00 ET
Arcadia Biosciences published news for 2021 q4
SEC form 6
2022-02-07 16:26 ET
Arcadia Biosciences published news for 2021 q4
SEC form 6
2021-12-20 17:03 ET
Arcadia Biosciences published news for 2021 q3
SEC form 6
2021-11-19 16:29 ET
Arcadia Biosciences published news for 2021 q3
SEC form 10
2021-11-15 16:53 ET
Arcadia Biosciences published news for 2021 q3
SEC form 6
2021-11-15 16:08 ET
Arcadia Biosciences published news for 2021 q3
SEC form 10
2021-11-15 00:00 ET
Arcadia Biosciences published news for 2021 q3
SEC form 8
2021-11-15 00:00 ET
Arcadia Biosciences published news for 2021 q3
SEC form 6
2021-10-12 13:44 ET
Arcadia Biosciences published news for 2021 q3
SEC form 6
2021-09-07 16:48 ET
Arcadia Biosciences published news for 2021 q2
SEC form 10
2021-08-16 17:06 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-08-16 16:10 ET
Arcadia Biosciences published news for 2021 q2
SEC form 10
2021-08-16 00:00 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-08-02 16:57 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-07-20 16:00 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-07-06 16:02 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-07-02 15:32 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-06-07 17:14 ET
Arcadia Biosciences published news for 2021 q1
SEC form 6
2021-05-21 15:59 ET
Arcadia Biosciences published news for 2021 q1
SEC form 10
2021-05-17 17:05 ET
Arcadia Biosciences published news for 2021 q1
SEC form 6
2021-05-17 16:10 ET
Arcadia Biosciences published news for 2021 q1
SEC form 10
2021-05-17 00:00 ET
Arcadia Biosciences published news for 2021 q1
SEC form 6
2021-04-20 15:01 ET
Arcadia Biosciences published news for 2021 q1
SEC form 10
2021-03-31 17:00 ET
Arcadia Biosciences published news for 2020 q4
SEC form 6
2021-03-30 16:51 ET
Arcadia Biosciences published news for 2020 q4
SEC form 6
2021-02-24 15:48 ET
Arcadia Biosciences published news for 2020 q4
SEC form 6
2021-01-29 11:34 ET
Arcadia Biosciences published news for 2020 q4
SEC form 6
2020-12-22 12:32 ET
Arcadia Biosciences published news for 2020 q3
SEC form 6
2020-11-18 15:44 ET
Arcadia Biosciences published news for 2020 q3
SEC form 10
2020-11-13 14:47 ET
Arcadia Biosciences published news for 2020 q3
SEC form 6
2020-11-12 08:00 ET
Arcadia Biosciences published news for 2020 q3